Differences in e-Lung biomarker scores between treatment groups in post-hoc analysis of the ATLAS inhaled pirfenidone solution (AP01) for IPF clinical trial

Peter M. George, et al. (2024). Poster presented at American Thoracic Society (ATS) Conference